{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:10:17Z","timestamp":1793938217635,"version":"4.8.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"University of Eastern Finland (UEF) including Kuopio University Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s40266-022-00929-y","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T01:02:28Z","timestamp":1647306148000},"page":"199-207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Opioids and Falls Risk in Older Adults: A Narrative Review"],"prefix":"10.1007","volume":"39","author":[{"given":"Roosa-Emilia","family":"Virnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5069-5045","authenticated-orcid":false,"given":"Miia","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niina","family":"Karttunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline P.","family":"van Poelgeest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"van der Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirpa","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"929_CR1","unstructured":"EuroSafe. Injuries in the European Union, summary on injury statistics 2012\u20132014, 6th edn. Amsterdam: European Association for Injury Prevention and Safety Promotion; 2016. https:\/\/www.eurosafe.eu.com\/uploads\/inline-files\/EuropeSafe_Master_Web_02112016%20(2).pdf."},{"key":"929_CR2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.15585\/mmwr.mm6718a1","volume":"67","author":"E Burns","year":"2018","unstructured":"Burns E, Kakara R. Deaths from falls among persons aged \u2265 65 years\u2014United States, 2007\u20132016. Morb Mortal Wkly Rep. 2018;67:509\u201314.","journal-title":"Morb Mortal Wkly Rep"},{"key":"929_CR3","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/gerona\/glaa038","volume":"75","author":"A Yoshikawa","year":"2020","unstructured":"Yoshikawa A, Ramirez G, Smith ML, et al. Opioid use and the risk of falls, fall injuries and fractures among older adults: a systematic review and meta-analysis. J Gerontol A Biol Sci Med Sci. 2020;75:1989\u201395.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"929_CR4","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/EDE.0b013e3181e89905","volume":"21","author":"S Deandrea","year":"2010","unstructured":"Deandrea S, Lucenteforte E, Bravi F, et al. Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiol. 2010;21:658\u201368.","journal-title":"Epidemiol"},{"key":"929_CR5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059124","volume":"8","author":"A Tolppanen","year":"2013","unstructured":"Tolppanen A, Lavikainen P, Soininen H, et al. Incident hip fractures among community dwelling persons with Alzheimer\u2019s disease in a Finnish nationwide register-based cohort. PLoS ONE. 2013;8: e59124.","journal-title":"PLoS ONE"},{"issue":"372","key":"929_CR6","first-page":"e1","volume":"19","author":"LJ Seppala","year":"2018","unstructured":"Seppala LJ, van de Glind EMM, Daams JG, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: III. Others. J Am Med Dir Assoc. 2018;19(372):e1-372.e8.","journal-title":"J Am Med Dir Assoc"},{"key":"929_CR7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s12877-020-01887-z","volume":"20","author":"Y Li","year":"2020","unstructured":"Li Y, Liu M, Sun X, et al. Independent and synergistic effects of pain, insomnia, and depression on falls among older adults: a longitudinal study. BMC Geriatr. 2020;20:491.","journal-title":"BMC Geriatr"},{"key":"929_CR8","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/pme.12462","volume":"15","author":"B Stubb","year":"2014","unstructured":"Stubb B, Schofield P, Binnekade T, Patchay S, Sepehry A, Eggermon L. Pain is associated with recurrent falls in community-dwelling older adults: evidence from a systematic review and meta-analysis. Pain Med. 2014;15:1115\u201321.","journal-title":"Pain Med"},{"key":"929_CR9","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.pain.2013.07.029","volume":"154","author":"KV Patel","year":"2013","unstructured":"Patel KV, Guralnik JM, Dansie EJ, et al. Prevalence and impact of pain among older adults in the united states: findings from the 2011 national health and aging trends study. Pain. 2013;154:2649\u201357.","journal-title":"Pain"},{"issue":"3","key":"929_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.anclin.2019.04.012","volume":"37","author":"J Schwan","year":"2019","unstructured":"Schwan J, Sclafani J, Tawfik VL. Chronic pain management in the elderly. Anesthesiol Clin. 2019;37(3):547\u201360. https:\/\/doi.org\/10.1016\/j.anclin.2019.04.012.","journal-title":"Anesthesiol Clin"},{"key":"929_CR11","doi-asserted-by":"crossref","unstructured":"Lehti TE, Rinkinen MO, Aalto U et al. Prevalence of musculoskeletal pain and analgesic treatment among community dwelling older adults: changes from 1999 to 2019. Drugs Aging. 2021 (Online ahead of print)","DOI":"10.1007\/s40266-021-00888-w"},{"key":"929_CR12","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jpain.2010.11.011","volume":"12","author":"K Herr","year":"2011","unstructured":"Herr K. Pain assessment strategies in older patients. J Pain. 2011;12:S3\u201313.","journal-title":"J Pain"},{"key":"929_CR13","volume":"5","author":"W Achterberga","year":"2020","unstructured":"Achterberga W, Lautenbacherb S, Huseboc B, et al. Pain in dementia. Pain Rep. 2020;5: e803.","journal-title":"Pain Rep."},{"key":"929_CR14","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/ageing\/afs199","volume":"42","author":"A Abdulla","year":"2013","unstructured":"Abdulla A, Adams N, Bone M, et al. Guidance on the management of pain in older people. Age Ageing. 2013;42:i1\u201357.","journal-title":"Age Ageing"},{"issue":"1","key":"929_CR15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12877-017-0537-x","volume":"17","author":"S Rapo-Pylkk\u00f6","year":"2017","unstructured":"Rapo-Pylkk\u00f6 S, Haanp\u00e4\u00e4 M, Liira H. A one-year follow-up study of chronic pain in community-dwelling older adults with and without neuropathic pain. BMC Geriatr. 2017;17(1):152.","journal-title":"BMC Geriatr"},{"key":"929_CR16","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1526-4637.2009.00699.x","volume":"10","author":"American Geriatric Society (AGS) Panel on the Pharmacological Management of Persistent Pain in Older Persons","year":"2009","unstructured":"American Geriatric Society (AGS) Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. Pain Med. 2009;10:1062\u201383.","journal-title":"Pain Med"},{"key":"929_CR17","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jpain.2010.11.006","volume":"12","author":"FM Gloth","year":"2011","unstructured":"Gloth FM. Pharmacological management of persistent pain in older persons: focus on opioids and nonopioids. J Pain. 2011;12:S14-20.","journal-title":"J Pain"},{"key":"929_CR18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"DM Fick","year":"2019","unstructured":"Fick DM, Semla TP, Steinman M, et al. American geriatrics society 2019 updated AGS Beers criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67:674\u201394.","journal-title":"J Am Geriatr Soc"},{"key":"929_CR19","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3389\/fphar.2020.00648","volume":"11","author":"YM Weesie","year":"2020","unstructured":"Weesie YM, Hek K, Schermer TRJ, et al. Use of opioids increases with age in older adults: an observational study (2005\u20132017). Front Pharmacol. 2020;11:648.","journal-title":"Front Pharmacol"},{"issue":"4","key":"929_CR20","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/ageing\/afaa249","volume":"50","author":"LJ Seppala","year":"2021","unstructured":"Seppala LJ, Petrovic M, Ryg J, Bahat G, Topinkova E, Szczerbi\u0144ska K, van der Cammen TJM, Hartikainen S, Ilhan B, Landi F, Morrissey Y, Mair A, Guti\u00e9rrez-Valencia M, Emmelot-Vonk MH, Mora M\u00c1C, Denkinger M, Crome P, Jackson SHD, Correa-P\u00e9rez A, Knol W, Soulis G, Gudmundsson A, Ziere G, Wehling M, O'Mahony D, Cherubini A, van der Velde N. STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs. Age Ageing. 2021;50(4):1189\u201399. https:\/\/doi.org\/10.1093\/ageing\/afaa249.","journal-title":"Age Ageing."},{"key":"929_CR21","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.joca.2017.03.017","volume":"25","author":"W Lo-Ciganic","year":"2017","unstructured":"Lo-Ciganic W, Floden L, Lee JK, et al. Analgesic use and risk of recurrent falls in participants with or at risk of knee osteoarthritis: data from the osteoarthritis initiative. Osteoarthr Cartil. 2017;25:1390\u20138.","journal-title":"Osteoarthr Cartil"},{"key":"929_CR22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40266-018-0622-7","volume":"36","author":"LJ Seppal\u00e4","year":"2019","unstructured":"Seppal\u00e4 LJ, van der Velde N, Masud T, The EuGMS Special Interest Group on Pharmacology EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs), et al. Position on knowledge dissemination, management, and future research. Drugs Aging. 2019;36:299\u2013307.","journal-title":"Drugs Aging"},{"key":"929_CR23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1532-5415.2010.03234.x","volume":"59","author":"Panel on Prevention of Falls in Older Persons","year":"2011","unstructured":"Panel on Prevention of Falls in Older Persons. American Geriatrics Society and British Geriatrics Society: summary of the updated American Geriatrics Society\/British Geriatrics Society Clinical Practice Guideline for prevention of falls in older persons. J Am Geriatr Soc. 2011;59:148\u201357.","journal-title":"J Am Geriatr Soc"},{"key":"929_CR24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O'Mahony","year":"2015","unstructured":"O\u2019Mahony D, O\u2019Sullivan D, Byrne S, et al. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213\u20138.","journal-title":"Age Ageing"},{"key":"929_CR25","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/ggi.12589","volume":"16","author":"A Poudel","year":"2016","unstructured":"Poudel A, Ballokova A, Hubbard RE, et al. Algorithm of medication review in frail older people: focus on minimizing the use of high-risk medications. Geriatr Gerotol Int. 2016;16:1002\u201313.","journal-title":"Geriatr Gerotol Int"},{"issue":"3","key":"929_CR26","volume":"2018","author":"M Noble","year":"2010","unstructured":"Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;2018(3): CD006605.","journal-title":"Cochrane Database Syst Rev"},{"key":"929_CR27","volume":"13","author":"M Rekatsina","year":"2021","unstructured":"Rekatsina M, Paladini A, Drewes AM, et al. Efficacy and safety of Peripherally Acting \u03bc-Opioid Receptor Antagonist (PAMORAs) for the management of patients with opioid-induced constipation: a systematic review. Cureus. 2021;13: e16201.","journal-title":"Cureus."},{"key":"929_CR28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1533-2500.2008.00204.x","volume":"8","author":"J Pergolizzi","year":"2008","unstructured":"Pergolizzi J, B\u00f6ger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel. Pain Pract. 2008;8:287\u2013313.","journal-title":"Pain Pract"},{"key":"929_CR29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40266-016-0389-7","volume":"33","author":"G Pickering","year":"2016","unstructured":"Pickering G, Marcoux M, Chapiro S, David L, Rat P, Michel M, Wary B. An algorithm for neuropathic pain management in older people. Drugs Aging. 2016;33:575\u201383.","journal-title":"Drugs Aging"},{"key":"929_CR30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2015","unstructured":"Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: systematic review, meta-analysis and updated NeuPSIG recommendations. Lancet Neurol. 2015;14:162\u201373.","journal-title":"Lancet Neurol"},{"key":"929_CR31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-045418","volume":"11","author":"S Black-Tiong","year":"2021","unstructured":"Black-Tiong S, Gonzalez-Chica D, Stocks N. Trends in long-term opioid prescriptions for musculoskeletal conditions in Australian general practice: a national longitudinal study using MedicineInsight, 2012\u20132018. BMJ Open. 2021;11: e045418.","journal-title":"BMJ Open"},{"issue":"3","key":"929_CR32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-039238","volume":"11","author":"NM Edwards","year":"2021","unstructured":"Edwards NM, Varnum C, Overgaard S, Nikolajsen L, Christiansen CF, Pedersen AB. Risk factors for new chronic opioid use after hip fracture surgery: a Danish nationwide cohort study from 2005 to 2016 using the Danish multidisciplinary hip fracture registry. BMJ Open. 2021;11(3): e039238.","journal-title":"BMJ Open"},{"key":"929_CR33","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cger.2016.06.006","volume":"32","author":"JG Naples","year":"2016","unstructured":"Naples JG, Gellad WF, Hanlon JT. Managing pain in older adults: the role of opioid analgesics. Clin Geriatr Med. 2016;32:725\u201335.","journal-title":"Clin Geriatr Med"},{"key":"929_CR34","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2165\/00002512-200522080-00002","volume":"22","author":"K Auret","year":"2005","unstructured":"Auret K, Schug SA. Underutilization of opioids in elderly patients with chronic pain. Drugs Aging. 2005;22:641\u201354.","journal-title":"Drugs Aging"},{"key":"929_CR35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","volume":"10","author":"R Chou","year":"2009","unstructured":"Chou R, Fanciullo GJ, Fine PG, et al. American Pain Society-American Academy of pain medicine opioids guidelines panel: clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113\u201330.","journal-title":"J Pain"},{"key":"929_CR36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2016.12.021","volume":"38","author":"E Reeve","year":"2017","unstructured":"Reeve E, Thompson W, Farrell B. Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. Eur J Intern Med. 2017;38:3\u201311.","journal-title":"Eur J Intern Med"},{"key":"929_CR37","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2174\/138945010791170879","volume":"11","author":"P Niscola","year":"2010","unstructured":"Niscola P, Scaramucci L, Vischini G, Giovannini M, Ferrannini M, Massa P, Palumbo R. The use of major analgesics in patients with renal dysfunction. Curr Drug Targets. 2010;11:752\u20138.","journal-title":"Curr Drug Targets"},{"key":"929_CR38","unstructured":"Oregon pain guidance. Opioid conversion calculator. https:\/\/www.oregonpainguidance.org\/opioidmedcalculator\/. Accessed 30 Aug 2021."},{"key":"929_CR39","unstructured":"The Agency Medical Directors\u2019 Group. Opioid Dose Calculator. http:\/\/agencymeddirectors.wa.gov\/calculator\/dosecalculator.htm. Accessed 30 Aug 2021."},{"key":"929_CR40","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/bcpt.12289","volume":"116","author":"J M\u00f6ller","year":"2015","unstructured":"M\u00f6ller J, Laflamme L, S\u00f6derberg LK. CYP2D6-inhibiting drugs and the increased risk of fall-related injuries due to newly initiated opioid treatment\u2014a Swedish, register-based case-crossover study. Basic Clin Pharmacol Toxicol. 2015;116:134\u20139.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"929_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2149","author":"KR Crews","year":"2021","unstructured":"Crews KR, Monte AA, Huddart R, et al. Clinical pharmacogenetics implementation consortium guideline for CYP2D6, OPRM1, and COMT genotypes and select opioid therapy. Clin Pharmacol Ther. 2021. https:\/\/doi.org\/10.1002\/cpt.2149.","journal-title":"Clin Pharmacol Ther"},{"key":"929_CR42","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","volume":"84","author":"HS Smith","year":"2009","unstructured":"Smith HS. Opioid metabolism. Mayo Clin Proc. 2009;84:613\u201324.","journal-title":"Mayo Clin Proc"},{"key":"929_CR43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/gps.5018","volume":"34","author":"N Karttunen","year":"2019","unstructured":"Karttunen N, Taipale H, Hamina A, et al. Concomitant use of benzodiazepines and opioids in community-dwelling older people with or without Alzheimer\u2019s disease\u2014a nationwide register-based study in Finland. Int J Geriatr Psychiatr. 2019;34:280\u20138.","journal-title":"Int J Geriatr Psychiatr"},{"issue":"1382","key":"929_CR44","first-page":"e1","volume":"131","author":"S Hassamal","year":"2018","unstructured":"Hassamal S, Miotto K, Dale W, et al. Tramadol: understanding the risk of serotonin syndrome and seizures. Am J Med. 2018;131(1382):e1-1382.e6.","journal-title":"Am J Med"},{"key":"929_CR45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/jpmn.2001.25012","volume":"2","author":"S Young-McCaughan","year":"2001","unstructured":"Young-McCaughan S, Miaskowski C. Definition of and mechanism for opioid-induced sedation. Pain Manag Nurs. 2001;2:84\u201397.","journal-title":"Pain Manag Nurs"},{"key":"929_CR46","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/nuf.12266","volume":"53","author":"DR Dunwoody","year":"2018","unstructured":"Dunwoody DR, Jungquist CR. Sedation scales: do they capture the concept of opioid-induced sedation? Nurs Forum. 2018;53:399\u2013405.","journal-title":"Nurs Forum"},{"key":"929_CR47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.12998\/wjcc.v5.i3.73","volume":"5","author":"F Guerriero","year":"2017","unstructured":"Guerriero F. Guidance on opioids prescribing for the management of persistent non-cancer pain in older adults. World J Clin Cases. 2017;5:73\u201381.","journal-title":"World J Clin Cases."},{"key":"929_CR48","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00228-013-1499-3","volume":"69","author":"CE Dur\u00e1n","year":"2013","unstructured":"Dur\u00e1n CE, Azermai M, Vander Stichele RH. Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol. 2013;69:1485\u201396.","journal-title":"Eur J Clin Pharmacol"},{"key":"929_CR49","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jacc.2018.05.079","volume":"72","author":"R Freeman","year":"2018","unstructured":"Freeman R, Abuzinadah AR, Gibbons C, et al. Orthostatic hypotension: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72:1294\u2013309.","journal-title":"J Am Coll Cardiol"},{"key":"929_CR50","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s12603-017-0953-9","volume":"22","author":"A Luukkonen","year":"2018","unstructured":"Luukkonen A, Tiihonen M, Rissanen T, et al. Orthostatic hypotension and associated factors among home care clients aged 75 years or older\u2014a population-based study. J Nutr Health Aging. 2018;22:154\u20138.","journal-title":"J Nutr Health Aging"},{"key":"929_CR51","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s40266-020-00796-5","volume":"37","author":"G Rivasi","year":"2020","unstructured":"Rivasi G, Rafanelli M, Mossello E, et al. Drug-related orthostatic hypotension: beyond anti-hypertensive medications. drugs aging. 2020;37:725\u201338.","journal-title":"drugs aging"},{"key":"929_CR52","doi-asserted-by":"crossref","first-page":"s27","DOI":"10.1111\/pme.12915","volume":"16","author":"a chen","year":"2015","unstructured":"chen a, ashburn ma. cardiac effects of opioid therapy. pain med. 2015;16:s27\u201331.","journal-title":"pain med"},{"key":"929_CR53","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/cpt.1562","volume":"106","author":"e ram\u00edrez","year":"2019","unstructured":"ram\u00edrez e, rodr\u00edguez a, queiruga j, et al. severe hyponatremia is often drug induced: 10-year results of a prospective pharmacovigilance program. Clin Pharmacol Ther. 2019;106:1362\u201379.","journal-title":"Clin Pharmacol Ther"},{"key":"929_CR54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejim.2019.08.006","volume":"69","author":"H Falhammar","year":"2019","unstructured":"Falhammar H, Calissendorff J, Skov J, et al. Tramadol- and codeine-induced severe hyponatremia: a Swedish population-based case-control study. Eur J Intern Med. 2019;69:20\u20134.","journal-title":"Eur J Intern Med"},{"key":"929_CR55","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.amjmed.2014.10.046","volume":"128","author":"J Fournier","year":"2015","unstructured":"Fournier J, Yin H, Nessim SJ, et al. Tramadol for noncancer pain and the risk of hyponatremia. Am J Med. 2015;128:418-425.e5.","journal-title":"Am J Med"},{"key":"929_CR56","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/j.pain.0000000000001412","volume":"160","author":"H Taipale","year":"2019","unstructured":"Taipale H, Hamina A, Karttunen N, et al. Incident opioid use and risk of hip fracture among persons with Alzheimer disease: a nationwide matched cohort study. Pain. 2019;160:417\u201323.","journal-title":"Pain"},{"key":"929_CR57","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1017\/S1041610217002745","volume":"30","author":"ME Machado-Duque","year":"2018","unstructured":"Machado-Duque ME, Casta\u00f1o-Montoya JP, Medina-Morales DA, et al. Association between the use of benzodiazepines and opioids with the risk of falls and hip fractures in older adults. Int Psychogeriatr. 2018;30:941\u20136.","journal-title":"Int Psychogeriatr"},{"key":"929_CR58","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1532-5415.2011.03318.x","volume":"59","author":"M Miller","year":"2011","unstructured":"Miller M, St\u00fcrmer T, Azrael D, et al. Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc. 2011;59:430\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"929_CR59","unstructured":"MedStopper: MedStopper. https:\/\/medstopper.com\/. Accessed 8 Apr 2021."},{"key":"929_CR60","unstructured":"Desprescribing.org. https:\/\/deprescribing.org\/. Accessed 31 Jan 2022."},{"key":"929_CR61","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","volume":"175","author":"IA Scott","year":"2015","unstructured":"Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175:827\u201334.","journal-title":"JAMA Intern Med"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-022-00929-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-022-00929-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-022-00929-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T02:16:09Z","timestamp":1647828969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-022-00929-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["929"],"URL":"https:\/\/doi.org\/10.1007\/s40266-022-00929-y","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"8 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by University of Eastern Finland (UEF) including Kuopio University Hospital. No external source of funding was received for the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Virnes R-E, Tiihonen M, Karttunen N, van Poelgeest EP and van der Velde N have no conflicts of interest. Hartikainen S has received lecture fees from Astellas Pharma.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable<i>.<\/i>","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"This study does not contain any studies with human participants performed by any of the authors.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"For this type of study, formal consent is not required.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"For this type of study, formal consent is not required.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The idea for the article was by Sirpa Hartikainen, Eveline van Poelgeest and Natalie van der Velde. Roosa-Emilia Virnes, Miia Tiihonen and Sirpa Hartikainen performed the literature search and analysis, and Roosa-Emilia Virnes drafted the work. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}